Zeroharm Sciences Holo Oncolis Tablet

Zeroharm Sciences Holo Oncolis Tablet

Holo Oncolis from Zeroharm Sciences is a nutraceutical formulated with nano-formulated curcuminoids, peptides, triterpenoid saponins, bacosides and piperine. It is intended as adjunctive support alongside standard cancer care, formulated using a patent-pending encapsulation process aimed at improving the solubility and bioavailability of its ingredients. Bottle of 60 tablets, one month’s supply.

Key Features

• Nano-formulated curcuminoids, peptides, saponins and piperine
• Formulated for enhanced solubility and bioavailability
• Intended for use alongside standard medical care, not as a replacement
• Bottle of 60 tablets (one month’s supply) from Zeroharm Sciences

Composition

• Nano-formulated curcuminoids and peptides – 100 mg
• Triterpenoid saponins – 5 mg
• Bacosides a1, a2, a3 – 5 mg
• Piperine – 5 mg

Uses & Benefits

• Formulated with antioxidant and anti-inflammatory botanical extracts
• Intended to support general wellbeing and comfort alongside cancer care routines
• This is a nutraceutical product and is not intended to diagnose, prevent, treat or cure any disease

Directions for Use

• 2 tablets daily, or as directed by your healthcare professional

Precautions

• This is a nutraceutical product, not intended to diagnose, prevent, treat or cure any disease
• Do not refrigerate
• Consult your healthcare professional first if pregnant, breastfeeding, prone to food allergies, or under any medical treatment
• Do not exceed the recommended dosage

Storage

• Store in a cool, dry place away from direct sunlight; do not refrigerate
• Keep out of reach of children

Disclaimer

This is a nutraceutical product intended as adjunctive support, not a treatment or cure for cancer or any disease. This information is for general awareness and is not a substitute for professional medical advice, diagnosis or treatment. Please consult your oncologist before use.